• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素特异性蛋白酶 14(USP14)促进胰腺导管腺癌的增殖和转移。

Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma.

机构信息

Department of Gastroenterology, Taicang Affiliated Hospital of Soochow University, The First People's Hospital of Taicang, Taicang, 215400, Jiangsu Province, China.

出版信息

J Mol Histol. 2021 Apr;52(2):187-196. doi: 10.1007/s10735-020-09934-0. Epub 2021 Jan 4.

DOI:10.1007/s10735-020-09934-0
PMID:33394290
Abstract

Previous studies have shown aberrant expression of ubiquitin-specific protease 14 (USP14) in multiple malignancies, suggesting an important role of USP14 in tumorigenesis. However, the functional role of USP14 in pancreatic ductal adenocarcinoma (PDAC) has never been elucidated. In this study, we found that USP14 was remarkably upregulated in PDAC tissues compared with normal pancreatic tissues. Notably, Kaplan-Meier curves showed that high expression of USP14 predicted significantly worse prognosis in PDAC patients than low expression of USP14. To determine whether USP14 could regulate the proliferation, apoptosis and metastasis of PDAC cells, we knocked down endogenous USP14 or overexpressed exogenous USP14 in Panc-1 and BxPC-3 cells. Using MTT assays, colony formation analyses, flow cytometry assays, and cell invasion and migration assays, we found that knockdown of USP14 attenuated proliferation, induced apoptosis and restrained invasion and migration of PDAC cells. Overexpression of USP14 could enhance proliferation, prevent apoptosis and promote invasion and migration of PDAC cells. In addition, USP14 could regulate the expression of cyclin D1, PCNA and E-cadherin, three important carcinogenic factors, in PDAC cells. These findings suggest that USP14 might play an important role in promoting the tumorigenesis of PDAC and thus be a promising therapeutic target to prevent PDAC progression.

摘要

先前的研究表明,泛素特异性蛋白酶 14(USP14)在多种恶性肿瘤中表达异常,提示 USP14 在肿瘤发生中具有重要作用。然而,USP14 在胰腺导管腺癌(PDAC)中的功能作用尚未阐明。在这项研究中,我们发现与正常胰腺组织相比,USP14 在 PDAC 组织中显著上调。值得注意的是,Kaplan-Meier 曲线表明,与 USP14 低表达的 PDAC 患者相比,USP14 高表达预示着预后显著更差。为了确定 USP14 是否可以调节 PDAC 细胞的增殖、凋亡和转移,我们在 Panc-1 和 BxPC-3 细胞中敲低内源性 USP14 或过表达外源性 USP14。通过 MTT 分析、集落形成分析、流式细胞术分析以及细胞侵袭和迁移分析,我们发现敲低 USP14 可减弱 PDAC 细胞的增殖,诱导凋亡并抑制侵袭和迁移。过表达 USP14 可以增强增殖,阻止凋亡并促进 PDAC 细胞的侵袭和迁移。此外,USP14 可以调节 PDAC 细胞中三个重要致癌因子 cyclin D1、PCNA 和 E-cadherin 的表达。这些发现表明,USP14 可能在促进 PDAC 的肿瘤发生中发挥重要作用,因此可能成为预防 PDAC 进展的有前途的治疗靶标。

相似文献

1
Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma.泛素特异性蛋白酶 14(USP14)促进胰腺导管腺癌的增殖和转移。
J Mol Histol. 2021 Apr;52(2):187-196. doi: 10.1007/s10735-020-09934-0. Epub 2021 Jan 4.
2
A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma.USP14-TAZ 自扩增环驱动胰腺导管腺癌的进展和肝转移。
Cell Death Differ. 2023 Jan;30(1):1-15. doi: 10.1038/s41418-022-01040-w. Epub 2022 Jul 29.
3
SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells.沉默调节蛋白1(SIRT 1)过表达与胰腺导管腺癌(PDAC)转移相关,并促进PDAC细胞的迁移和生长。
Med Sci Monit. 2016 May 12;22:1593-600. doi: 10.12659/msm.896697.
4
The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma.USP22 通过 DYRK1A 促进胰腺导管腺癌中癌细胞的生长。
Gene. 2020 Oct 20;758:144960. doi: 10.1016/j.gene.2020.144960. Epub 2020 Jul 17.
5
An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.长链非编码 RNA PANDAR 的表达增加促进胰腺导管腺癌细胞增殖并抑制细胞凋亡。
Biomed Pharmacother. 2017 Nov;95:685-691. doi: 10.1016/j.biopha.2017.08.124. Epub 2017 Sep 7.
6
ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF/BETA pathway and is regulated by miR-26a-5p.ARNTL2 通过 TGF/BETA 通路促进胰腺导管腺癌的进展,并且受到 miR-26a-5p 的调控。
Cell Death Dis. 2020 Aug 10;11(8):692. doi: 10.1038/s41419-020-02839-6.
7
Downregulation of ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell proliferation and metastasis, but promotes apoptosis.泛素特异性蛋白酶14(USP14)的下调抑制乳腺癌细胞的增殖和转移,但促进细胞凋亡。
J Mol Histol. 2016 Feb;47(1):69-80. doi: 10.1007/s10735-015-9650-3. Epub 2015 Dec 28.
8
RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.RACK1过表达与胰腺导管腺癌的生长及不良预后相关。
Exp Mol Pathol. 2016 Oct;101(2):176-186. doi: 10.1016/j.yexmp.2016.08.001. Epub 2016 Aug 3.
9
MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1.微小 RNA-766 通过直接靶向 ETS1 抑制胰腺导管腺癌的恶性生物学行为。
Mol Med Rep. 2019 Feb;19(2):1380-1387. doi: 10.3892/mmr.2018.9770. Epub 2018 Dec 14.
10
A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.一个有潜力的预后标志物和治疗靶点:SPOCK1 促进胰腺导管腺癌细胞的增殖、转移和凋亡。
J Cell Biochem. 2020 Jan;121(1):743-754. doi: 10.1002/jcb.29320. Epub 2019 Sep 3.

引用本文的文献

1
USP14/S100A11 axis promote colorectal cancer progression by inhibiting cell senescence.USP14/S100A11轴通过抑制细胞衰老促进结直肠癌进展。
Cell Death Dis. 2025 May 15;16(1):384. doi: 10.1038/s41419-025-07724-8.
2
USP14 Positively Modulates Head and Neck Squamous Carcinoma Tumorigenesis and Potentiates Heat Shock Pathway through HSF1 Stabilization.USP14正向调节头颈部鳞状细胞癌的肿瘤发生,并通过稳定热休克因子1(HSF1)增强热休克通路。
Cancers (Basel). 2023 Sep 1;15(17):4385. doi: 10.3390/cancers15174385.
3
USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration.

本文引用的文献

1
Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide.USP14 的抑制增强了乳腺癌对恩杂鲁胺的敏感性。
J Exp Clin Cancer Res. 2019 May 24;38(1):220. doi: 10.1186/s13046-019-1227-7.
2
USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer.USP14 作为一种新型预后标志物,通过 Akt/ERK 信号通路促进胃癌对顺铂耐药。
Cancer Med. 2018 Nov;7(11):5577-5588. doi: 10.1002/cam4.1770. Epub 2018 Sep 17.
3
Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
胰腺导管腺癌的 USP 研究:表达、预后意义和免疫浸润的综合生物信息学分析。
Biomed Res Int. 2022 Dec 20;2022:6109052. doi: 10.1155/2022/6109052. eCollection 2022.
4
A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma.USP14-TAZ 自扩增环驱动胰腺导管腺癌的进展和肝转移。
Cell Death Differ. 2023 Jan;30(1):1-15. doi: 10.1038/s41418-022-01040-w. Epub 2022 Jul 29.
5
The role of ubiquitination and deubiquitination in tumor invasion and metastasis.泛素化和去泛素化在肿瘤侵袭和转移中的作用。
Int J Biol Sci. 2022 Mar 6;18(6):2292-2303. doi: 10.7150/ijbs.69411. eCollection 2022.
6
The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer.USP14和PSMD14表达在非小细胞肺癌中的预后价值
Ann Transl Med. 2021 Jun;9(12):1019. doi: 10.21037/atm-21-2748.
7
Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases.靶向蛋白酶体相关去泛素化酶的小分子抑制剂。
Int J Mol Sci. 2021 Jun 9;22(12):6213. doi: 10.3390/ijms22126213.
抑瘤微小 RNA-124a 通过靶向泛素特异性蛋白酶 14 抑制非小细胞肺癌细胞的干性并增强吉非替尼敏感性。
Cancer Lett. 2018 Jul 28;427:74-84. doi: 10.1016/j.canlet.2018.04.022. Epub 2018 Apr 24.
4
Global incidence and mortality rates in pancreatic cancer and the association with the Human Development Index: decomposition approach.全球胰腺癌发病率和死亡率及其与人类发展指数的关系:分解方法。
Public Health. 2018 Mar;156:87-91. doi: 10.1016/j.puhe.2017.12.015. Epub 2018 Feb 3.
5
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
6
The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators.去泛素化酶USP5通过调节细胞周期调节因子促进胰腺癌。
Oncotarget. 2017 Aug 3;8(39):66215-66225. doi: 10.18632/oncotarget.19882. eCollection 2017 Sep 12.
7
Improving theranostics in pancreatic cancer.改善胰腺癌的诊疗一体化
J Surg Oncol. 2017 Jul;116(1):104-113. doi: 10.1002/jso.24625. Epub 2017 May 17.
8
Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma.泛素特异性肽酶 14 的过表达预示着食管鳞状细胞癌的不良预后。
Thorac Cancer. 2017 Jul;8(4):344-349. doi: 10.1111/1759-7714.12453. Epub 2017 May 16.
9
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.蛋白酶体相关去泛素化酶泛素特异性蛋白酶14通过去泛素化和稳定雄激素受体来调节前列腺癌增殖。
Cell Death Dis. 2017 Feb 2;8(2):e2585. doi: 10.1038/cddis.2016.477.
10
Knockdown of Ubiquitin-Specific Protease 14 (USP14) Inhibits the Proliferation and Tumorigenesis in Esophageal Squamous Cell Carcinoma Cells.泛素特异性蛋白酶14(USP14)的敲低抑制食管鳞状细胞癌细胞的增殖和肿瘤发生。
Oncol Res. 2017 Jan 26;25(2):249-257. doi: 10.3727/096504016X693164. Epub 2016 Sep 13.